Evaluation of the Incidence of Relapses in Patients With Biotin-treated Progressive Multiple Sclerosis
Condition:   Progressive Multiple Sclerosis Interventions:   Drug: biotin;   Other: propensity score Sponsors:   University Hospital, Clermont-Ferrand;   OFSEP (Observatoire Français de la Sclérose en Plaques);   SFSEP (Société Francophone de la Sclérose en Plaques);   MedDay Pharmaceuticals SA Enrolling by invitation (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 11, 2018 Category: Research Source Type: clinical trials